We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$38.5B
AUM Growth
+$4.48B
(+13%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
2,364
New
149
Increased
1,180
Reduced
895
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$275M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$221M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$193M |
| 4 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$188M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$230M |
| 2 |
Spectrum Brands
SPB
|
+$81.6M |
| 3 |
Chevron
CVX
|
+$79.8M |
| 4 |
Pfizer
PFE
|
+$66.7M |
| 5 |
K
Kellanova
K
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.09% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Technology | 9.81% |
| 4 | Consumer Staples | 7.93% |
| 5 | Communication Services | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Westlake Corp
WLK
$9.46B
| $4.11M | 0.01% |
59,935
-45,967
| -43% | -$3.34M |
|
|
FNFG
1127
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $4.11M | 0.01% |
+435,480
| New | +$3.98M |
|
1128
iShares China Large-Cap ETF
FXI
$4.31B
| $4.1M | 0.01% |
88,845
-1,392
| -2% | -$68.9K |
|
1129
Allison Transmission
ALSN
$10.1B
| $4.09M | 0.01% |
139,964
-113,055
| -45% | -$3.51M |
|
1130
Raymond James Financial
RJF
$32.5B
| $4.08M | 0.01% |
102,822
-8,496
| -8% | -$330K |
|
1131
CSX Corp
CSX
$98.6B
| $4.08M | 0.01% |
375,084
-617,133
| -62% | -$7.15M |
|
1132
Aecom
ACM
$9.07B
| $4.07M | 0.01% |
123,085
-389,006
| -76% | -$12.8M |
|
|
BRLI
1133
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $4.07M | 0.01% |
98,709
+24,827
| +34% | +$890K |
|
1134
W.P. Carey
WPC
$17.1B
| $4.06M | 0.01% |
70,274
-101,104
| -59% | -$6.32M |
|
|
FINL
1135
DELISTED
Finish Line
FINL
| $4.05M | 0.01% |
145,480
+10,368
| +8% | +$268K |
|
1136
Evercore
EVR
$13.1B
| $4.04M | 0.01% |
74,964
+9,954
| +15% | +$508K |
|
|
PLCM
1137
DELISTED
POLYCOM INC
PLCM
| $4.04M | 0.01% |
353,359
+78,202
| +28% | +$1.02M |
|
|
AMSG
1138
DELISTED
Amsurg Corp
AMSG
| $3.99M | 0.01% |
57,004
+23,262
| +69% | +$1.55M |
|
1139
WaFd
WAFD
$2.72B
| $3.97M | 0.01% |
170,140
+13,672
| +9% | +$306K |
|
1140
Lithia Motors
LAD
$7.78B
| $3.96M | 0.01% |
34,996
+7,619
| +28% | +$811K |
|
|
CYNO
1141
DELISTED
Cynosure, Inc. Class A
CYNO
| $3.94M | 0.01% |
102,256
-17,520
| -15% | -$616K |
|
|
CBM
1142
DELISTED
Cambrex Corporation
CBM
| $3.94M | 0.01% |
89,630
-10,148
| -10% | -$420K |
|
1143
Comtech Telecommunications
CMTL
$51.8M
| $3.93M | 0.01% |
135,137
+39,020
| +41% | +$1.18M |
|
1144
Middleby
MIDD
$6.05B
| $3.92M | 0.01% |
34,953
-26,900
| -43% | -$2.88M |
|
1145
Granite Construction
GVA
$5.45B
| $3.92M | 0.01% |
110,353
+38,192
| +53% | +$1.39M |
|
|
SAVE
1146
DELISTED
Spirit Airlines, Inc.
SAVE
| $3.91M | 0.01% |
63,014
-56,473
| -47% | -$3.85M |
|
1147
iShares MSCI Taiwan ETF
EWT
$10B
| $3.91M | 0.01% |
123,894
-437
| -0.4% | -$14.1K |
|
1148
M/I Homes
MHO
$3.83B
| $3.9M | 0.01% |
158,259
+2,649
| +2% | +$63.1K |
|
1149
America Movil
AMX
$78.1B
| $3.9M | 0.01% |
182,942
-12,570
| -6% | -$265K |
|
1150
Agilent Technologies
A
$39.1B
| $3.88M | 0.01% |
100,435
-357,273
| -78% | -$14.8M |
|
Similar funds
DAM
First Trust Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, First Trust Advisors held 2,364 positions worth $38.5B, up 13% from $34B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
First Trust Advisors deployed $4.55B of net new capital in Q2 2015, opening 149 new positions and adding to 1,180 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Chevron, an estimated $79.8M trimmed.
- First Trust Advisors's largest Q2 2015 buy was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q2 2015, an estimated $275M increase.
- First Trust Advisors's biggest Q2 2015 reduction was Chevron, cutting an estimated $79.8M.
- First Trust Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $230M.
- First Trust Advisors's ten largest holdings make up 14% of its $38.5B portfolio in Q2 2015.
- First Trust Advisors opened 149 new positions and closed 134 in Q2 2015.
- First Trust Advisors's portfolio value rose 13% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q2 2015, filed 4 Aug 2015.